Does a 62-year-old woman with headache and an empty sella require further evaluation?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 30, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Management of Incidental Empty Sella in a 62-Year-Old Woman with Headache

Yes, this patient requires pituitary hormone testing at initial presentation, regardless of symptoms. The 2025 Pituitary Society guidelines explicitly recommend baseline endocrine evaluation for all patients with incidentally discovered empty sella 1.

Recommended Initial Evaluation

Mandatory Hormonal Testing

All patients with empty sella require comprehensive pituitary function assessment 1:

  • Morning cortisol and ACTH (with dynamic testing if cortisol suggests hypocortisolism)
  • Free T4 and TSH
  • Prolactin
  • IGF-1 (insulin-like growth factor 1)
  • LH, FSH, and estradiol (given she is postmenopausal at age 62)

Why Testing is Essential Despite "Incidental" Finding

The evidence reveals a critical disconnect between symptoms and actual pituitary dysfunction. In 402 patients with primary empty sella, 29% of those diagnosed incidentally had at least one hormonal axis deficiency 1. The specific deficiencies found in incidentally diagnosed cases included:

  • Hypocortisolism: 13.5%
  • Hypothyroidism: 2.8%
  • Hypogonadism: 8.5%
  • Growth hormone deficiency: 12.5%

The absence of obvious endocrine symptoms does not predict normal pituitary function - symptoms have only a 71% negative predictive value for ruling out hypopituitarism 1.

Important Clinical Context

The Headache Connection

While her "heaviness of head" prompted the imaging, headache does not establish causation with empty sella 2, 3. However, this symptom pattern is commonly reported in empty sella patients, particularly in middle-aged women 3. The headache itself does not change the management algorithm but warrants documentation.

Risk Factors for Hypopituitarism

Factors that increase likelihood of pituitary dysfunction in empty sella patients 1:

  • Male sex (though this patient is female)
  • Total vs. partial empty sella (total carries higher risk)
  • Clinical suspicion (her headache may represent subtle manifestation)
  • History of traumatic brain injury

Imaging Considerations

If the empty sella diagnosis is clear on existing imaging and clinical/laboratory assessment enables diagnosis, no additional baseline imaging is required 1. The 2025 guidelines specifically cite a 27-year-old man with partial empty sella detected during evaluation for limb weakness as an example where initial imaging plus clinical assessment was sufficient 1.

However, dedicated pituitary MRI protocol should be obtained if:

  • The nature of the lesion is uncertain
  • There are atypical features
  • Uncertainty exists about appropriate management

Follow-Up Strategy

If Initial Testing is Normal:

Repeat hormonal evaluation at 24-36 months 4, as progression from partial to total empty sella can be associated with hormonal deterioration (P = 0.006) 1.

If Hypopituitarism is Detected:

Follow current guidelines for specific hormone deficiencies identified 1. Hormone replacement should be initiated promptly, as demonstrated by a recent case where a 53-year-old woman with empty sella and multiple anterior pituitary deficiencies experienced significant clinical improvement after hormone replacement 5.

Common Pitfalls to Avoid

  1. Assuming "incidental" means "benign": Empty sella carries substantial risk of clinically significant hypopituitarism even without overt symptoms 5

  2. Relying on symptoms alone: The lack of classic endocrine symptoms does not exclude hormone deficiency 1

  3. Dismissing the finding as purely radiological: While often asymptomatic, empty sella can represent a marker of evolving anterior hypopituitarism 5

  4. Overlooking the need for long-term surveillance: Even with normal initial testing, hormonal deterioration can occur over time 1

Bottom Line

This 62-year-old woman requires comprehensive pituitary hormone testing now 1. The testing should include morning cortisol, ACTH, free T4, TSH, prolactin, IGF-1, LH, FSH, and estradiol. If imaging clearly demonstrates empty sella and no additional diagnostic uncertainty exists, no further imaging is needed at this time 1. Regardless of initial results, she will need repeat hormonal assessment in 2-3 years given the risk of progressive pituitary dysfunction 1, 4.

References

2
Research

Headache and the primary empty sella syndrome.

Archives of otolaryngology--head & neck surgery, 1986

3
Research

Empty sella and headache.

Headache, 1994

4
Research

Empty sella syndrome: an update.

Pituitary, 2024

Related Questions

In a patient with chronic migraines and worsening headache whose brain CT reveals a partially empty sella, should this be considered an incidental finding or warrant further endocrine and neuro‑ophthalmologic evaluation?
In a primary care patient with a partially empty sella identified on a CT scan performed for migraines, what is the appropriate management?
What is the association between empty sella syndrome and migraine?
Can untreated central diabetes insipidus cause persistent foot pain in a non‑diabetic patient with growth‑hormone‑deficiency‑related hypoglycemia, polyuria, and high serum osmolality?
In a pregnant woman with empty sella syndrome, how should I evaluate for pituitary hormone deficiencies and manage treatment and monitoring during pregnancy?
What is the most reliable first-line investigation for suspected active tuberculosis?
What is the appropriate management for a 49-year-old woman not on thyroid medication who has a TSH of 0.892 µIU/mL and a T3 (triiodothyronine) level of 25.7 units?
A 48-year-old woman taking hydrochlorothiazide 12.5 mg daily and nifedipine extended‑release 30 mg daily has blood pressure 140/90 mm Hg and cannot use amlodipine due to peripheral edema; what additional treatment options are appropriate?
What is the appropriate treatment for comedonal acne in a 22-year-old female?
Is an elevated neurofilament light chain (NfL) level of 1.3 pg/mL (reference < 1.29 pg/mL) clinically significant in a 39‑year‑old man with memory complaints?
Can nitrates be administered in a patient with acute coronary syndrome who is currently normotensive due to norepinephrine and dobutamine infusions?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.